VY-3-135

Overview

VY-3-135 is a potent, orally active, and stable ACSS2 inhibitor with an IC 50 value of 44 nM. VY-3-135 is specific to ACSS2 among the AcCoA synthetase family of enzymes . VY-3-135 does not inhibit ACSS1 or ACSS3 enzymatic activity. VY-3-135 can be used for the research of breast cancer .

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Obesity | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Acetyl-CoA Carboxylase

Product Information

• Catalog No.: HY-145953
• CAS No.: 1824637-41-3
• Molecular Formula: C26H27N3O3
• Molecular Weight: 429.51
• Purity: 99.62%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (5.82 mM); Clear solution
• Availability: In-stock

Source

Original product source